GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solasia Pharma KK (TSE:4597) » Definitions » 5-Year EBITDA Growth Rate

Solasia Pharma KK (TSE:4597) 5-Year EBITDA Growth Rate : 24.70% (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Solasia Pharma KK 5-Year EBITDA Growth Rate?

Solasia Pharma KK's EBITDA per Share for the three months ended in Jun. 2024 was 円-1.42.

During the past 3 years, the average EBITDA Per Share Growth Rate was 50.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Solasia Pharma KK was 50.30% per year. The lowest was -35.90% per year. And the median was -3.10% per year.


Competitive Comparison of Solasia Pharma KK's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solasia Pharma KK's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Solasia Pharma KK's 5-Year EBITDA Growth Rate falls into.



Solasia Pharma KK 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Solasia Pharma KK  (TSE:4597) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Solasia Pharma KK 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Solasia Pharma KK's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Solasia Pharma KK Business Description

Traded in Other Exchanges
Address
2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.

Solasia Pharma KK Headlines

No Headlines